Evidence map›Paper›PMID 28089078›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2017

hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury.

Yongmin Yan, Wenqian Jiang, Youwen Tan, Shengqiang Zou, Hongguang Zhang, Fei Mao, Aihua Gong, Hui Qian, Wenrong Xu

Open access · bronzeAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 192 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
192citing papers in PubMed, 2 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

192 citing papers in PubMed, 2 syntheses or guidelines pooled it, 339 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic Function.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Stem cell-based therapeutic strategies for liver aging.Liver research (Beijing, China) · 2025
    Review
  19. Article
  20. Review

132 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yongmin YanLiver Disease and Cancer Institute, School of Medicine, Jiangsu University, 212013 Zhenjiang, Jiangsu, People's Republic of China. Electronic address: ujsyym@163.com.
Wenqian JiangLiver Disease and Cancer Institute, School of Medicine, Jiangsu University, 212013 Zhenjiang, Jiangsu, People's Republic of China.
Youwen TanThe Affiliated Third Hospital of Zhenjiang, Jiangsu University, 212013 Zhenjiang, Jiangsu, People's Republic of China.
Shengqiang ZouThe Affiliated Third Hospital of Zhenjiang, Jiangsu University, 212013 Zhenjiang, Jiangsu, People's Republic of China.
Hongguang ZhangThe Affiliated Third Hospital of Zhenjiang, Jiangsu University, 212013 Zhenjiang, Jiangsu, People's Republic of China.
Fei MaoLiver Disease and Cancer Institute, School of Medicine, Jiangsu University, 212013 Zhenjiang, Jiangsu, People's Republic of China.
Aihua GongLiver Disease and Cancer Institute, School of Medicine, Jiangsu University, 212013 Zhenjiang, Jiangsu, People's Republic of China.
Hui QianLiver Disease and Cancer Institute, School of Medicine, Jiangsu University, 212013 Zhenjiang, Jiangsu, People's Republic of China; Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, 212013 Zhenjiang, Jiangsu, People's Republic of China.
Wenrong XuLiver Disease and Cancer Institute, School of Medicine, Jiangsu University, 212013 Zhenjiang, Jiangsu, People's Republic of China; Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, 212013 Zhenjiang, Jiangsu, People's Republic of China. Electronic address: icls@ujs.edu.cn.
Jiangsu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosomes are small biological membrane vesicles secreted by various cells, including mesenchymal stem cells (MSCs). We previously reported that MSC-derived exosomes (MSC-Ex) can elicit hepatoprotective effects against toxicant-induced injury. However, the success of MSC-Ex-based therapy for treatment of liver diseases and the underlying mechanisms have not been well characterized. We used human umbilical cord MSC-derived exosome (hucMSC-Ex) administrated by tail vein or oral gavage at different doses and, in engrafted liver mouse models, noted antioxidant and anti-apoptotic effects and rescue from liver failure. A single systemic administration of hucMSC-Ex (16 mg/kg) effectively rescued the recipient mice from carbon tetrachloride (CCl

Indexed as

Oxidative StressAnimalsApoptosisCell LineChemical and Drug Induced Liver InjuryDisease Models, AnimalExosomesGene Knockdown TechniquesGlutathione PeroxidaseGlutathione Peroxidase GPX1HepatocytesHumansLiverLiver FailureMesenchymal Stem CellsMiceGlutathione PeroxidaseGlutathione Peroxidase GPX1Oxidantsexosomeglutathione peroxidase1hepatic injurymesenchymal stem celloxidative stress

Identifiers

PMID28089078
PMCPMC5368592
OpenAlexW2571034953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.